See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Research Area · Gene Regulation
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13373 |
2',3',5'- |
10302-78-0 | ≥95% |
|
2010-08-05 | 6.038779811465 | 2-3-5-triacetyl-5-azacytidine | inhibitors inhibits inhibition DNA methyltransferases epigenetics methylation myelodysplastic syndromes cancers prodrugs 5-azacytidine 5-azacitidine azacytidine azacitidine rapid absorption o rally | 6.038779811465 | |||
| 9000786 |
3- |
78582-17-9 | ≥98% |
|
2011-06-15 | 60.266809392265 | 3-deaza-2-deoxyadenosine | c3dA | inhibitors genes regulation immunology lymphocytes cytolysis nucleosides adenine nitrogen DNA | 60.266809392265 | ||
| 10547 |
4- |
- | ≥95% |
|
✓ | 2010-08-11 | 9.999471111111 | 4-pentynoyl-coenzyme-a-trifluoroacetate-salt | Click Tag™ 4-pentynoyl-CoA | 50347-32-5 click chemistry proteins acetylation posttranslational post-translational post translational modify modification acetyl-CoA acetyl-coenzyme A lysine histons acetyl click-it click it click tag click-tag 14-pentynoyl-coa(adamantyl) indole | 9.999471111111 | |
| 11164 |
5- |
320-67-2 | ≥95% |
|
2012-02-16 | 7.670126563710 | 5-azacytidine | Antibiotic U 18496; Mylosar; NSC 102816; U 18496; NSC 103-627; 5-AzaC; Ladakamycin; WR 183027 | 52934-49-3 292869-98-8 ledakamycin azacitidine 5-azacitidine 5 azacitidine 5 azacytidine 5-AZCR 5-AZC 5-AC methyltransferases histones cancers epigenetics cytidine inhibitors DNA RNA inhibits inhibition diseases cells | 7.670126563710 | ||
| 9000593 |
A1- |
1094529-42-6 | ≥90% (trans isomer mix) |
|
✓ | 2012-04-27 | 215.087868123029 | a1-phytoprostane-i | PPA1; Phytoprostane A1; 16-A1-Phytoprostane | A1 Phytoprostane I A1 Phytoprostane-I A1-Phytoprostane I PPAs phytoprostanes cyclopentenones isoprostanes reactive oxygen species ROS α-linolenic acids plants ketones groups ring structures isoforms cyclizations carbons glutathiones glutathione-S-transferases phytoalexins biosynthesis genes expressions metabolisms oxidative stress | 215.087868123029 | |
| 10010567 | Acetyl Lysine Monoclonal Antibody (Clone 7F8) | - | 2008-06-16 | 24.108653314916 | acetyl-lysine-monoclonal-antibody-clone-7f8 | HDACs HATs histones deacetylases acetyltransferases epigenetic antibodies antiserum antisera (Ac)K AcK acetyl-lysine (Ac)Lys AcLys Enzyme-linked immunoabsorbent assays WB western blots blotting immunoblotting ICC immunocytochemistry | 24.108653314916 | |||||
| 13725 |
Acetyl Lysine Polyclonal Antibody- |
- | 2009-12-04 | 1.385359116022 | acetyl-lysine-polyclonal-antibody-biotin | antibodies WB western blots immunoblotting blotting immunoprecipitation IP ELISA immunofluorescence IF proteins conjugated HATs HDACs histone acetyltransferases deacetylated deacetylases proteins cancers anti-cancer anticancer anti post-translational | 1.385359116022 | |||||
| 13726 | Acetyl Lysine Polyclonal Antibody HRP Conjugate | - | 2009-12-04 | 1.385359116022 | acetyl-lysine-polyclonal-antibody-hrp-conjugate | antibodies WB western blots immunoblotting blotting immunoprecipitation IP ELISA immunofluorescence IF proteins conjugated HATs HDACs histone acetyltransferases deacetylated deacetylases proteins cancers anti-cancer anticancer anti | 1.385359116022 | |||||
| 10009542 | Anhydrotetracycline (hydrochloride) | 13803-65-1 | ≥98% |
|
2009-10-28 | 10.853149171271 | anhydrotetracycline-hydrochloride | tetracycline repressors TetR transcription tetO genes expression reverse revTetR co-repressor | 10.853149171271 | |||
| 10946 | Ash2L (human recombinant) | - | ≥90% |
|
2011-06-29 | 12.972715102576 | ash2l-human-recombinant | Set1/Ash2 Histone Methyltransferase Complex Subunit Ash2 Isoform A; Absent, small, or homeotic discs 2-like | epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex human homolog Drosophilia ash2 transcription | 12.972715102576 | ||
| 11571 | Bexarotene New | 153559-49-0 | ≥98% |
|
2012-04-06 | 47.635666052793 | bexarotene | LGD 1069; SR 11247; Ro 26-4455; LG 100069; Targretin | retinoid X receptors ligands agonist RXR genes expression cancers alzheimers diseases apoptosis angiogenesis metastasis cells proliferations β-amyloid amyloids βamyloid LG 100069 1069 69 LG-100069 LG-1069 LG-69 LGD 1069 LGD-1069 LGD1069 LG100069 LG1069 LG69 RO 26-4455 RO26-4455 RO-26-4455 RO 264455 RO-264455 RO264455 SR 11247 SR-11247 SR11247 targret targretin targretyn targrexin | 47.635666052793 | ||
| 10960 | Bisdemethoxycurcumin | 24939-16-0 | ≥98% |
|
2011-08-09 | 23.565733578882 | bisdemethoxycurcumin | BDMC | curcumin activators macrophages phagocytosis 1α,25-dihydroxyvitamin D, amyloid-β Alzheimer’s diseases cancers transcription genes expression p300 Wnt/β-catenin iNOS inflammation bisdemethoxy curcumin 33171-05-0 | 23.565733578882 | ||
| 13124 | BIX01294 (hydrochloride hydrate) | - | ≥98% |
|
2009-12-03 | 37.100217184225 | bix01294-hydrochloride-hydrate | euchromatin genes expressions epigenetics G9a histones methyltransferase HMTase embryogenesis imprinting lymphocytes development inhibitors proteins GLP stem cells 935693-62-2 | 37.100217184225 | |||
| 11507 | BRD1 bromodomain (human recombinant) New | - | ≥95% |
|
2012-03-01 | 15.723401238237 | brd1-bromodomain-human-recombinant | Bromodomain containing 1; DKFZp686F0325; BR140-like protein; BRL; BRPF1; BRPF2; Bromodomain and PHD finger-containing protein 2 | BRD1 genes expression histones chromatin acetylation bromodomains epigenetics schizophrenia bipolar disorders BRD-1 BRDs | 15.723401238237 | ||
| 11071 |
BRD2 bromodomain 1 (human recombinant; GST- |
- | ≥95% |
|
2011-10-21 | 21.617085211800 | brd2-bromodomain-1-human-recombinant-gst-tagged | RNF3; Bromodomain containing 4; RING3 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host | 21.617085211800 | ||
| 11070 |
BRD2 bromodomain 2 (human recombinant; GST- |
- | ≥95% |
|
2011-10-21 | 19.476201233899 | brd2-bromodomain-2-human-recombinant-gst-tagged | RING3; RNF3; Bromodomain containing 4 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host | 19.476201233899 | ||
| 11069 | BRD2 bromodomains 1 and 2 (human recombinant) New | - | ≥90% |
|
2011-12-20 | 22.742155953254 | brd2-bromodomains-1-and-2-human-recombinant | Bromodomain containing 2; RNF3; RING3 | BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases | 22.742155953254 | ||
| 11068 |
BRD4 bromodomain 1 (human recombinant; GST- |
- | ≥60% |
|
2011-10-21 | 31.131678012537 | brd4-bromodomain-1-human-recombinant-gst-tagged | MCAP; Bromodomain containing 4; HUNK1 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts | 31.131678012537 | ||
| 600520 |
BRD4 bromodomain 1 TR- |
- |
|
2012-04-25 | 87.870599080453 | brd4-bromodomain-1-tr-fret-assay-kit | kits assays measures measurements acetylations histones lysines epigenetics regulations genes transcriptions acetylated residues small proteins bromodomains nucleosomes chromatins structures expression BET family tandem Extra Terminal BRD2 BRD3 BRDT cells cellular inflammatory inflammation mitosis viral host virus viral/host interactions binds binding tails couples marks transcriptional targets promoters molecules inhibitors bromodomain/histone I-BET JQ-1 therapeutics human diseases complexes activated macrophages protection protects bacteria-induced sepsis lipopolysaccharides lipopolysaccharide-triggered endotoxic shock enantiomerically pure (+)-JQ1 (+)-JQ-1 2 bromodomain-peptides displacement inhibits inhibitors probes oncogenesis oncology cancers homogeneous TR-FRET time-resolved fluorescence resonance energy transfer characterization bromodomain/acetylated interactions fluorophores europium Eu3+ chelates biotinylated ligands allophycocyanin APC-labeled avidins biotins | 87.870599080453 | ||||
| 11066 |
BRD4 bromodomain 2 (human recombinant; GST- |
- | ≥95% |
|
2011-10-21 | 23.292605823785 | brd4-bromodomain-2-human-recombinant-gst-tagged | MCAP; Bromodomain containing 4; HUNK1 | BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts | 23.292605823785 | ||
| 600530 |
BRD4 bromodomain 2 TR- |
- |
|
2012-04-26 | 88.919981796503 | brd4-bromodomain-2-tr-fret-assay-kit | kits assays measures measurements acetylations histones lysines epigenetics regulations genes transcriptions acetylated residues small proteins bromodomains nucleosomes chromatins structures expression BET family tandem Extra Terminal BRD2 BRD3 BRDT cells cellular inflammatory inflammation mitosis viral host virus viral/host interactions binds binding tails couples marks transcriptional targets promoters molecules inhibitors bromodomain/histone I-BET JQ-1 therapeutics human diseases complexes activated macrophages protection protects bacteria-induced sepsis lipopolysaccharides lipopolysaccharide-triggered endotoxic shock enantiomerically pure (+)-JQ1 (+)-JQ-1 1 bromodomain-peptides displacement inhibits inhibitors probes oncogenesis oncology cancers homogeneous TR-FRET time-resolved fluorescence resonance energy transfer characterization bromodomain/acetylated interactions fluorophores europium Eu3+ chelates biotinylated ligands allophycocyanin APC-labeled avidins biotins | 88.919981796503 | ||||
| 11052 | BRD4 bromodomains 1 and 2 (human recombinant) New | - | ≥90% |
|
2011-12-20 | 25.119793084056 | brd4-bromodomains-1-and-2-human-recombinant | HUNK1; Bromodomain containing 4; MCAP | BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases | 25.119793084056 | ||
| 11509 | BRD9 bromodomain (human recombinant) New | - | ≥95% |
|
2012-04-20 | 65.853947880323 | brd9-bromodomain-human-recombinant | Bromodomain-containing 9 | BRD9 genes expressions histones chromatin acetylation bromodomains epigenetics BET domains transcription Extra Terminal domain BRDs BRDT inflammatory mitosis viral/host interactions Rhabdomyosarcoma antigen MU-RMS-40.8 | 65.853947880323 | ||
| 11548 | BRDT bromodomain 1 (human recombinant) New | - | ≥95% |
|
2012-03-01 | 15.723401238237 | brdt-bromodomain-1-human-recombinant | BRD6; CT9; RING3-like protein; Cancer/testis antigen 9; BRD-containing protein testis specific | BRD-T genes expression histones chromatin acetylation bromodomains epigenetics BET domains Extra Terminal RING3 PEST Bromodomain testis specific BRDs BRD T | 15.723401238237 | ||
| 11284 | BRG1 bromodomain (human recombinant) New | - | ≥95% |
|
2012-03-05 | 12.837710969321 | brg1-bromodomain-human-recombinant | BRG1-associated factor 190A; BAF190A Mitotic growth and transcription activator; ATP-dependent helicase SMARCA4; Protein BRG-1 | BRG1 genes expressions histones chromatin acetylation bromodomains epigenetics SWI/SNF SWI SNF cancers tumors suppressors Protein brahma homolog 1 | 12.837710969321 | ||
| 11289 | BRM bromodomain (human recombinant) New | - | ≥95% |
|
2012-03-01 | 8.128331573859 | brm-bromodomain-human-recombinant | SWI/SNF ATPase; SMARCA2A/B | BRD1 genes expressions histones chromatin acetylation bromodomains epigenetics SWI/SNF SWI SNF ATP dependent chromatin SWI/SNF-related, matrix associated, actin-dependent regulator of chromatin | 8.128331573859 | ||
| 10005019 | CAY10433 | 537034-17-6 | >98% |
|
2005-01-05 | 26.725718232044 | cay10433 | BML-210; N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide | HDAC deacetylases histone inhibits inhibitors inhibition cancer cells differentiation gene expression regulation Trichostatin A nuclear extracts deacetylation transcription factors FOXO3 SIRT1 H2O2 hydrogen peroxides BML210 | 26.725718232044 | ||
| 10009796 | CAY10602 | 374922-43-7 | ≥95% |
|
2009-07-15 | 19.163443830570 | cay10602 | SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB | 19.163443830570 | |||
| 13146 | CAY10603 | 1045792-66-2 | ≥95% |
|
2009-06-18 | 41.899042431909 | cay10603 | HDAC 6 inhibitors inhibits inhibition tubulin microtubule pancreatic cancers SAHA HDAC6 HDAC-6 HDACs HDACIs potent selective cells | 41.899042431909 | |||
| 10857 | CAY10654 Exclusive | 1298023-69-4 | ≥98% |
|
✓ | 2011-06-21 | 1.903637200736 | cay10654 | CAY-10654 CAY 10654 quorum sense sensing signal signaling genes regulations infectious diseases lipids bacteria pseudomonas aeruginosa AHLs p. N-acylated-L-Homoserine lactones transcriptional activators LasR virulence factors immunosuppression leukocytes lymphocytes concanavalin A cytotoxicity | 1.903637200736 | ||
| 13172 | CBHA | 174664-65-4 | ≥98% |
|
2009-06-24 | 20.309815262430 | cbha | Histone Deacetylase Inhibitor II; m-Carboxycinnamic Acid bis-Hydroxamide | histones deacetylase HDACs HDAC1 HDAC3 apoptosis cancers neuroblastoma tumors retinoic acids inhibitors inhibits inhibition | 20.309815262430 | ||
| 13156 | Chaetocin | 28097-03-2 | ≥95% |
|
2010-10-18 | 18.632886024146 | chaetocin | histones methyltransferases HMTs genes expressions epigenetics inhibitors oxidative stress cancers theoredoxin reductase-1 TrxR1 inhibits inhibition chetocin chaetocin A (+)-chaetocin piperazines | 18.632886024146 | |||
| 13501 |
Chromosome Associated Protein- |
- |
|
2009-09-22 | 0E-12 | chromosome-associated-protein-c-polyclonal-antibody-aa-281-297 | CAP-C | antibodies SMC WB western blots immunoblotting blotting hCAP-C hCAPC hCAP C hSMC1 hCAP-E hCAP E hCAPE hSMC3 chromosomes structured maintenance | 0E-12 | |||
| 11010 | Core Histones (human) | - | ≥95% |
|
2011-10-07 | 18.612207388499 | core-histones-human | HeLa Core Histones | histones DNA nucleosomes chromatin HDAC HAT HMT HDEM H2A H2B H3 H4 proteins acetylation genes transcriptions methylation demethylation phosphorylation regulation | 18.612207388499 | ||
| 11288 |
CREB- |
- | ≥95% |
|
✓ | 2012-04-24 | 70.298392324768 | creb-binding-protein-bromodomain-human-recombinant | CREBBP; CBP; cAMP-response-element-binding protein binding protein | CREBBP genes expressions histones chromatin acetylation bromodomains epigenetics CREB p53 cAMP response element-binding protein | 70.298392324768 | |
| 11166 | Decitabine New | 2353-33-5 | ≥98% |
|
2012-02-27 | 9.013102558266 | decitabine | Dacogen; 5-aza-2’-Deoxycytidine; NSC 127716; DAC | β-decitabine 105597-46-4 123795-43-7 5-azadeoxycytidine 5-azadCyd 5-aza-CdR inhibitors inhibition inhibits epigenetics DNA methylation genes expression methyltransferases hypomethylation mutagenic | 9.013102558266 | ||
| 700390 |
Demethylase (Jumonji- |
- |
|
2010-05-26 | 28.154262474787 | demethylase-jumonji-type-activity-assay-kit | kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 | 28.154262474787 | ||||
| 13479 | DNA Methyltransferase 1 Monoclonal Antibody (Clone 60B1220.1) | - |
|
2009-06-29 | 0.179671823204 | dna-methyltransferase-1-monoclonal-antibody-clone-60b1220-1 | DNMT1 | WB Western blots immunoblotting IHC ChIP IP DNMT 1 blotting immunohistochemistry immunoprecipitation | 0.179671823204 | |||
| 13481 | DNA Methyltransferase 2 Monoclonal Antibody (Clone 102B1259.2) | - |
|
2009-07-13 | 0E-12 | dna-methyltransferase-2-monoclonal-antibody-clone-102b1259-2 | DNMT2 | WB Western blots immunoblotting DNMT-2 monoclonals blotting DNMT 2 blotting | 0E-12 | |||
| 13480 | DNA Methyltransferase 2 Polyclonal Antibody | - |
|
2009-07-13 | 0.199635359116 | dna-methyltransferase-2-polyclonal-antibody | DNMT2 | WB Western blots immunoblotting DNMT 2 blotting DNMT-2 | 0.199635359116 | |||
| 13483 |
DNA Methyltransferase 3a Monoclonal Antibody - |
- | 2009-07-15 | 0E-12 | dna-methyltransferase-3a-monoclonal-antibody-biotinylated-clone-64b814-1 | DNMT3a | ELISA DNMT3a Enzyme-linked immunosorbent assays | 0E-12 | ||||
| 13484 | DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B1446) | - |
|
2009-07-15 | 0E-12 | dna-methyltransferase-3a-monoclonal-antibody-clone-64b1446 | DNMT3a | WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry IHC immunohistochemistry | 0E-12 | |||
| 13482 | DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B814.1) | - |
|
2009-07-01 | 0.199635359116 | dna-methyltransferase-3a-monoclonal-antibody-clone-64b814-1 | DNMT3a | WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry | 0.199635359116 | |||
| 13485 | DNA Methyltransferase 3b Monoclonal Antibody (Clone 52A1018) | - |
|
2009-07-01 | 0.199635359116 | dna-methyltransferase-3b-monoclonal-antibody-clone-52a1018 | DNMT3b | WB Western blots immunoblotting DNMT3b immunoprecipitation immunofluorescence immunocytochemistry ChIP immunohistochemistry IHC IP ICC IF blotting | 0.199635359116 | |||
| 10770 | DNA Methyltransferase 3L (human recombinant) | - | ≥95% |
|
2011-06-08 | 2.540563835710 | dna-methyltransferase-3l-human-recombinant | DNMT3L; DNMT3-Like Protein | DNA methyltransferases s-adenosylmethionine CpG methylation lysines proteins DNMT3a DNMT3b histones cysteine ADD PWWP mTase | 2.540563835710 | ||
| 11178 |
DPY- |
- | ≥95% |
|
2012-01-05 | 14.152052839174 | dpy-30-human-recombinant | DPY-30-like protein; hDPY-30; SAF19 | epigenetics methyltransferase histones H3K4 genes regulations MLL proteins subunits Ash2L MLL sore complex DPY30 methylation C. elegans XX mutations XO growth development homodimer monomers WDR5 WDR-5 WDR 5 RbBP5 basal rates DPY-30L DPY30L hDPY30 SAF-19 | 14.152052839174 | ||
| 10628 | EED (human recombinant) | - | 95 |
|
2010-12-03 | 0E-12 | eed-human-recombinant | Embryonic Ectoderm Development | 0E-12 | |||
| 10569 | Ellagic Acid | 476-66-4 | ≥95% |
|
2010-10-13 | 8.133806015960 | ellagic-acid | Lagistase; TBBD; Gallogen | polyphenols, antioxidants, cancers inflammation cytochrome P450s CYP450 epigenetics genes expression histones modifications alizarin yellow G 91006 elagostasine 77415-21-5 124590-32-5 PRMTs inflammatory anti-carcinogenic anti-mutagenic organ-preserving antimutagenic antiinflammatory Acid Benzoaric Benzoaric Acid Acid Ellagic Ellagic Acid | 8.133806015960 | ||
| 11076 |
Epigenetics Screening Library (96- |
- | 2011-11-09 | 25.669649126438 | epigenetics-screening-library-96-well | epigenetics libraries screens | 25.669649126438 | |||||
| 10009798 |
EX- |
49843-98-3 | ≥98% |
|
2009-10-23 | 28.387292817679 | ex-527 | sirtuins SIRT1 histones deacetylase HDAC energy metabolism inflammation inhibitors p53 DNA damage 848193-68-0 848193-69-1 | 28.387292817679 | |||
| 10353 | G9a (human recombinant) | - | ≥70% |
|
2011-03-08 | 17.008637329521 | g9a-human-recombinant | EHMT2; Euchromatic Histone-Lysine N-Methyltransferase 2; KMT1C | lysines methylation methyltransferases genes silencing repression proteins recombinants set domain-containing pluripotency H3K9 GLP active | 17.008637329521 | ||
| 10755 |
G9a- |
- | ≥95% |
|
2011-10-13 | 18.767345337971 | g9a-like-protein-human-recombinant | Eu HMTase 1; EHMT1; GLP; Euchromatic Histone-Lysine N-Methyltransferase 1; KMT1D | lysine methylation methyltransferase genes silencing repression SET domain histones modifications GLP H3K9 BIX-01294 UNC0638 inhibitors inhibits inhibition SAR monomethylate dimethylate BIX01294 BIX 01294 UNC-0638 UNC 0638 active | 18.767345337971 | ||
| 13841 | GANT 61 | 500579-04-4 | ≥98% |
|
2011-04-20 | 70.787052639656 | gant-61 | NSC 136476 | Hedgehog transcription factors genes expression GLI cancer glioblastomas antagonists development regulation GANT61 GANT-61 pyridines pyrimidines NSC136476 NSC-136476 TFs | 70.787052639656 | ||
| 10566 | Garcinol | 78824-30-3 | ≥95% |
|
2011-10-25 | 9.634610820401 | garcinol | Camboginol | inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics | 9.634610820401 | ||
| 10782 | Gcn5 (human recombinant) New | - | ≥80% |
|
2011-12-05 | 24.213892198032 | gcn5-human-recombinant | Lysine acetyltransferase 2A; General control of amino acid synthesis protein 5-like 2; KAT2A; STAF97 | epigenetics modifications histones acetylation cancers GNAT N-acetyltransferases enzymes STAGA TFTC SAGA ATAC H3K14 H3K9 H3K18 H4K8 H4K16 H3 H2B KAT2B p300/CBP associated factors Spt-Ada-GCN5-aceytltransferase Ada Two-A containing CoASH Gcn-5 N-acetyltransferases enzymatic subunits complexes proteins active | 24.213892198032 | ||
| 13355 | Geldanamycin | 30562-34-6 | ≥98% |
|
2010-07-29 | 35.265105447297 | geldanamycin | NSC 122750 | NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors 2,5-Cyclohexadiene-1,4-Diones 1,4-Benzoquinones 1,2-Benzoquinones p-Benzoquinones-o-Benzoquinones Benzoquinones Benzodiones Quinones geldanomycin GDM NSC122750 NSC-122750 NSC 122750 AC-6794 BRN 1633093 geldanamicin 30562-34-6 antibiotic U29135 U-29135 U 29135 AC1NQZ81 ligands GRP94 Hsp 90 | 35.265105447297 | ||
| 10576 | HC Toxin | 83209-65-8 | ≥95% |
|
2010-11-10 | 24.217044198895 | hc-toxin | Toxin I (Helminthosporium carbonum) | inhibitors histones deacetylases HDACs cancers genes regulation regulates regulators epigenetics HC-toxins cell-permable cells permable 15-lipoxygenase-1 15-LO-1 LOs lipoxygenase 15 1 tetrapeptides peptides helminthosporium carbonums cochliobolus maize pathogens Isomerases Amino Acid Acid Isomerases Amino Racemases Amino Acid Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases | 24.217044198895 | ||
| 10009231 | HDAC1 (human recombinant) | - | >10% by SDS-PAGE | 2006-12-06 | 28.775327141220 | hdac1-human-recombinant | Histone Deacetylase 1 | HDAC 1 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus GST-tagged baculovirus Sf9 active | 28.775327141220 | |||
| 10009377 | HDAC2 (human recombinant) | - | ≥70% by SDS-PAGE | 2006-12-06 | 23.566802079947 | hdac2-human-recombinant | Histone Deacetylase 2 | HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active | 23.566802079947 | |||
| 10009232 | HDAC3/NCOR2 (human recombinant) | - | ≥50% | 2006-12-06 | 38.905749309392 | hdac3-ncor2-human-recombinant | Histone Deacetylase 3 | HDAC 3 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active | 38.905749309392 | |||
| 10009379 | HDAC5 (human recombinant) | - | ≥90% by SDS-PAGE | 2006-12-06 | 32.033977900551 | hdac5-human-recombinant | Histone Deacetylase 5 | HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active | 32.033977900551 | |||
| 10009465 | HDAC6 (human recombinant) | - | ≥80% | 2007-06-14 | 22.816166595834 | hdac6-human-recombinant | GenBank Accession No. BC069243; Histone Deacetylase 6 | HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 active | 22.816166595834 | |||
| 19380 | HDAC8 (human recombinant) | - | ≥95% |
|
2009-04-03 | 20.800361240968 | hdac8-human-recombinant | HDAC 8 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active | 20.800361240968 | |||
| 10009466 | HDAC9 (human recombinant) | - | ≥95% | 2007-06-14 | 16.569378453038 | hdac9-human-recombinant | GenBank Accession No. NM 178423; Histone Deacetylase 9 | histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active | 16.569378453038 | |||
| 10261 | Histone H2A (Xenopus recombinant) | - | ≥95% |
|
2011-10-13 | 9.979322603891 | histone-h2a-xenopus-recombinant | histones DNA nucleosome chromatin HDACs HAT H2A H2B H3 H4 octomers dimers genes transcription regulation acetylation methylation phosphorylation tetramers cores regulate ubiquitylation sumoylation biotinylation | 9.979322603891 | |||
| 10262 | Histone H2B (Xenopus recombinant) | - | ≥95% |
|
2010-03-19 | 10.538693250059 | histone-h2b-xenopus-recombinant | histones DNA nucleosomes chromatin HDAC HAT H2A H3 H4 proteins FL full legnth acetylation genes transcriptions methylation phophorylation regulation | 10.538693250059 | |||
| 13784 | Histone H3.3 Polyclonal Antibody | - |
|
2010-05-07 | 5.939042357274 | histone-h3-3-polyclonal-antibody | H3.3B; H3.3A; H3F3A; H3F3B | histones antibodies immunohistochemistry IHC western blotting blots immunoblotting WB H2A H2B H3 H4 H-2A H-2B H-3 H-4 H 2A 2B 3 4 proteins nuclear DNA cells biology chromatin research epigenetics genes regulation modification histones | 5.939042357274 | |||
| 10263 | Histone H3 (human recombinant) | - | ≥95% |
|
2010-03-22 | 33.692926130550 | histone-h3-human-recombinant | histones DNA nucleosomes chromatin HDAC HAT H2A H2B H4 acetylation methylation phosphorylation | 33.692926130550 | |||
| 10264 | Histone H4 (human recombinant) | - | >95% |
|
2010-09-07 | 8.883149171271 | histone-h4-human-recombinant | H4; Histone H4 | 8.883149171271 | |||
| 11512 | HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New | - |
|
2012-01-16 | 0E-12 | hmgb1-monoclonal-antibody-clone-img19n10b7 | High Mobility Group Protein B1; HMG1 | high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB | 0E-12 | |||
| 11514 | HMGB1 Monoclonal Antibody (Clone IMG19N12A1) | - |
|
0E-12 | hmgb1-monoclonal-antibody-clone-img19n12a1 | High Mobility Group Protein B1; HMG1 | high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting | 0E-12 | ||||
| 11513 | HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New | - |
|
2012-01-16 | 0E-12 | hmgb1-monoclonal-antibody-clone-img19n15f4 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC | 0E-12 | |||
| 11515 |
HMGB1 Polyclonal Antibody (aa 100- |
- |
|
2012-01-20 | 0E-12 | hmgb1-polyclonal-antibody-aa-100-150 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC | 0E-12 | |||
| 11516 |
HMGB1 Polyclonal Antibody (aa 25- |
- |
|
2012-01-30 | 0E-12 | hmgb1-polyclonal-antibody-aa-25-75 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting | 0E-12 | |||
| 13295 | HNHA | 926908-04-5 | ≥98% |
|
2009-09-03 | 23.011531893520 | hnha | Histone Deacetylase Inhibitor VI | inhibitors inhibits inhibition histones deacetylase HDACs cancers fibrosarcoma HT1080 cells hyperacetylation p21 genes expressions transcription cycles arrest tumor growth murine xenograph human umbilical vein endothelial HUVECs tubes formation migration vascular endothelial factors VEGF retinal neovascularization angiogenesis | 23.011531893520 | ||
| 11235 |
HP1- |
- | ≥95% |
|
2012-05-03 | 81.581588704727 | hp1-human-recombinant | Chromobox Homolog 5; Heterochromatin Protein 1-α; CBX5; Antigen p25 | epigenetics heterochomatin chromodomains histones H3K9 Chromoshadow domain HP-1 HP1α HP1 α HP1s HP1β HP1ɣ hinge domain SETDB1 methylation homodimerization DNA damage response DDR | 81.581588704727 | ||
| 13782 | I2PP2A/SET Polyclonal Antibody | - |
|
2010-05-10 | 2.167182320442 | i2pp2a-set-polyclonal-antibody | Template-Activating Factor I; Inhibitor of granzyme A-activated DNase; Phosphatase 2A Inhibitor; PHAPII | antibodies WB western blots blotting immunoblotting histones INHAT1 INHAT 1 coactivators transcription cells TAF1α TAF 1α TAF1β TAF 1β SETs INHAT-1 protein SET SET/I2PP2A TAF-1 TAF 1 TAF1 TAF-1beta TAF-1.beta. IGAAD | 2.167182320442 | |||
| 13924 |
IκBα (Phospho- |
- | 2010-09-29 | 0E-12 | i-b-phospho-ser32-36-monoclonal-antibody-biotin-clone-39a1413 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser EIA ELISA biotins biotinylated inflammation genes regulation signal transduction | 0E-12 | |||||
| 13923 |
IκBα (Phospho- |
- |
|
2010-09-29 | 12.893068809643 | i-b-phospho-ser32-36-monoclonal-antibody-clone-39a1413 | antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target immunoprecipitation IP serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser genes regulation inflammation signal transduction | 12.893068809643 | ||||
| 10641 | JGB1741 Exclusive | 1256375-38-8 | ≥98% |
|
✓ | 2011-06-20 | 17.811325966850 | jgb1741 | ILS-JGB-1741 | inhibitors SIRT1 breasts cancers cells proliferation apoptosis p53 histones acetylation genes energy homeostasis regulation deacetylases sirtuins NAD+ inhibits inhibition SIRT2 SIRT3 ILS JGB 1,741 1741 SIRTs JGB-1741 JGB-1,741 | 17.811325966850 | |
| 10336 | JMJD2A (human recombinant) | - | ≥95% |
|
2010-12-01 | 17.414083026396 | jmjd2a-human-recombinant | JHDM3A; KDM4A; Jumonji Domain Containing 2A | lysine (K)-specific demethylase 4A Epigenetics Histone Demethylase chromatin regulator dioxygenase JmjC active | 17.414083026396 | ||
| 11299 |
JMJD2A- |
- | ≥95% |
|
✓ | 2012-05-08 | 110.723606945540 | jmjd2a-strep-tagged-human-recombinant | KDM4A; Jumonji Domain Containing 2A; JHDM3A | JMJD2A Jumonji domain demethylase epigenetics FDH KDM4Atrimethylllysine-specific JmjC protein hydroxylase Strep-Tactin StrepTactin Strep Tactin | 110.723606945540 | |
| 10335 | JMJD2D (human recombinant) | - | ≥75% |
|
2011-02-09 | 15.302862014869 | jmjd2d-human-recombinant | Jumonji Domain Containing 2D; KDM4D; Lysine-Specific Demethylase 4D | epigenetics histones demethylases chromatin regulators dioxygenases JmjC proteins jumanjis active | 15.302862014869 | ||
| 11300 |
JMJD2D- |
- | ≥70% |
|
✓ | 2012-05-08 | 113.753599052880 | jmjd2d-strep-tagged-human-recombinant | KDM4D; Lysine-specific Demethylase 4D; Jumonji Domain Containing 2D | JMJD2D Jumonji domain demethylase epigenetics FDH KDM4D JmjC proteins hydroxylase Strep Tactin StrepTactin Strep-Tactin | 113.753599052880 | |
| 11237 |
JMJD2E- |
- | ≥75% |
|
✓ | 2012-05-08 | 124.786284837323 | jmjd2e-strep-tagged-human-recombinant | Jumonji Domain Containing 2E; KDM4D-Like | JMJD2D Jumonji domain demethylase epigenetics FDH KDM4D JmjC protein hydroxylase Strep-Tactin Strep Tactin StrepTactin KDM4DL | 124.786284837323 | |
| 13787 |
JMJD6 Peptide Affinity- |
- |
|
2010-05-13 | 4.662667001506 | jmjd6-peptide-affinity-purified-polyclonal-antibody | Jumonji Domain Containing 6; PTDSR | antibodies western blots blotting immunoblotting nuclear protein JMJC domains histones H3 H4 H 3 H 4 H-3 H-4 chromatin epigenetics genes regulations modification | 4.662667001506 | |||
| 11232 |
(−)- |
1268524-71-5 | ≥98% |
|
✓ | 2012-04-23 | 107.848419726214 | -jq1 | BET bromodomain inhibitors inhibits inhibition BRD4 BRD2 transcription cancers extra terminal domains proteins BRD3 cells inflammatory inflammation genes expression mitosis viral viruses histones chromatin JQ 1 JQ-1 (±)-JQ1 ±-JQ1 | 107.848419726214 | ||
| 11187 |
(+)- |
1268524-70-4 | ≥98% |
|
✓ | 2012-04-23 | 220.321955079750 | -jq1 | BET bromodomain inhibitors inhibits inhibition BRD4 BRD2 transcription cancers JQ-1 JQ 1 extra terminal domains BRD3 cells genes expression inflammatory inflammation viral viruses mitosis histones chromatin (±)-JQ1 ±-JQ1 10741 | 220.321955079750 | ||
| 10245 | LSD1 (human recombinant) | - | ≥50% |
|
2009-06-03 | 5.453445769118 | lsd1-human-recombinant | AOF2; NPAO; Lysine-Specific Demethylase 1; BHC110; p110b; KDM1 | recombinant humans E.coli histones tumors suppressor CoREST lysine specific demethylase 1 proteins enzymes active | 5.453445769118 | ||
| 13174 | M 344 | 251456-60-7 | ≥98% |
|
2009-07-24 | 25.973145718231 | m-344 | D237; Histone Deacetylase Inhibitor III; MS 344 | HDACs inhibitors inhibits inhibitions histones deacetylases HDAC1 HDAC6 cancers squamous carcinoma radiation cells cycles arrest apoptosis endometrial ovarian M344 MS344 M-344 MS-344 | 25.973145718231 | ||
| 13771 | MBD1 Monoclonal Antibody (Clone 100B272.1) | - |
|
2010-03-31 | 0E-12 | mbd1-monoclonal-antibody-clone-100b272-1 | Methyl-CpG-Binding Domain 1 | antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 1 MBD 2 MBD 3 MBD 4 | 0E-12 | |||
| 13772 | MBD1 Polyclonal Antibody | - |
|
2010-03-31 | 0E-12 | mbd1-polyclonal-antibody | Methyl-CpG-Binding Domain 1 | antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 1 MBD 2 MBD 3 MBD 4 | 0E-12 | |||
| 13773 | MBD2/3 Monoclonal Antibody (Clone 106B691) | - |
|
2010-04-06 | 0E-12 | mbd2-3-monoclonal-antibody-clone-106b691 | Methyl-CpG-Binding Domain 2/3 | antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 2/3 MBD-2/3 MBD 1 MBD 2 MBD 3 MBD 4 MBD2-3 MBD 2-3 | 0E-12 | |||
| 13777 | MBD2 Binding Zinc Finger Polyclonal Antibody | - |
|
2010-05-06 | 0E-12 | mbd2-binding-zinc-finger-polyclonal-antibody | Methyl-CpG-Binding Domain 2; MIZF; HINFP; Histone H4 Transcription Factor | antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 2/3 MBD-2/3 MBD 1 MBD 2 MBD 3 MBD 4 WB western blotting blots immunoblotting histones deacetylase humans tissues chromatin research epigenetics genes regulations | 0E-12 | |||
| 11286 |
MBD2 (human recombinant; methyl binding domain aa 150- |
- | ≥95% |
|
2012-03-27 | 105.630555555555 | mbd2-human-recombinant-methyl-binding-domain-aa-150-220 | Methyl Cytosine Binding Domain 2; Methyl-CpG Binding Domain Protein 2 | Methyl CpG binding domains genes expression DNA chromatin MBD epigenetics CpG islands methylation MBDs 5-methylcytosine 5mC breast cancer tumors | 105.630555555555 | ||
| 11287 |
MeCp2 (human recombinant; methyl binding domain aa 77- |
- | ≥95% |
|
2012-04-20 | 105.630555555555 | mecp2-human-recombinant-methyl-binding-domain-aa-77-166 | Methyl-CpG Binding Protein 2 | Methyl CpG binding domains genes expressions DNA chromatin MBD epigenetics CpG islands MBDs 5-methylcytosine 5mC neurological Rett Syndrome MeCp-2 protein | 105.630555555555 | ||
| 13775 | MeCP2 Polyclonal Antibody | - |
|
2010-04-27 | 0E-12 | mecp2-polyclonal-antibody | Methyl-CpG-Binding Protein 2 | antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 2/3 MBD-2/3 MBD 1 MBD 2 MBD 3 MBD 4 MBD2-3 MBD 2-3 | 0E-12 | |||
| 13778 | Metastasis Associated 1 Family Member 2 Polyclonal Antibody | - |
|
2010-05-04 | 8.700276243093 | metastasis-associated-1-family-member-2-polyclonal-antibody | p53 Target Protein in Deacetylase Complex; MTA2; MTA-L1 Protein; PID | WB IHC western blotting blots immunoblotting immunohistochemistry MTA-2 MTA 2 MTA-1 MTA 1 MTA-3 MTA 3 HDAC2 HDAC-2 HDAC 2 HDAC1 HDAC-1 HDAC 1 proteins chromatin deacetylase activity activities northern p53 | 8.700276243093 | |||
| 13727 | Methylated Lysine Polyclonal Antibody | - | 2009-12-04 | 9.272799263351 | methylated-lysine-polyclonal-antibody | WB western blots blotting immunoblotting IP immunoprecipitation ELISA antibodies SUV39H1 lysines proteins histones H3 genes expressions immunohistochemistry IHC | 9.272799263351 | |||||
| 13728 |
Methylated Lysine Polyclonal Antibody- |
- | 2009-12-04 | 6.933941068139 | methylated-lysine-polyclonal-antibody-biotin | WB western blots blotting immunoblotting IP immunoprecipitation ELISA antibodies SUV39H1 lysines proteins histones H3 | 6.933941068139 | |||||
| 13729 | Methylated Lysine Polyclonal Antibody HRP Conjugate | - | 2009-12-04 | 6.933941068139 | methylated-lysine-polyclonal-antibody-hrp-conjugate | WB western blots blotting immunoblotting ELISA antibodies SUV39H1 lysines proteins histones H3 | 6.933941068139 | |||||
| 11434 | Mithramycin A New | 18378-89-7 | ≥98% |
|
2012-05-01 | 73.940322283609 | mithramycin-a | A 2371; Antibiotic LA 7017; PA 144; NSC 24559; Plicamycin; Aureolic Acid | 1395-17-1 1403-98-1 12708-66-6 12708-67-7 23973-19-5 97666-60-9 219612-19-8 744999-90-4 807260-73-7 826336-23-6 899900-19-7 1195235-16-5 mithracin NSC-24559 NSC24559 PA144 PA-144 A2371 A-2371 plicatomycin anti-tumors neuroprotective antibiotics chemotherapeutics histones acetylation transcription factors chromatin regulation Sp1 inhibitors inhibits inhibition oncogene TRAIL cancers Streptomyces grieseus S. grieseus DNA apoptosis | 73.940322283609 | ||
| 10658 | MLL1 (human recombinant) New | - | ≥95% |
|
2011-12-21 | 0.478496503496 | mll1-human-recombinant | Lysine Methyltransferase 2A; ALL1; Mixed Lineage Leukemia 1; HRX; KMT2a | epigenetics methyltransferase histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY30 mixed lineage leukemia methylation lysine HOX Pol II WAR c-terminal SET1 WIN binds binding DPY-30 WARD genomic | 0.478496503496 | ||
| 10756 | MLL1/WAR complex (human recombinant) New | - | ≥90% |
|
2012-01-04 | 14.152052839174 | mll1-war-complex-human-recombinant | Mixed-Lineage Leukemia-1; MLL Core Complex | epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin active | 14.152052839174 | ||
| 10945 | MLL1/WARD complex (human recombinant) New | - | ≥90% |
|
2012-01-04 | 16.762033767337 | mll1-ward-complex-human-recombinant | Mixed-Lineage Leukemia-1; KMT2A; MLL Core Complex | epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin WAR active | 16.762033767337 | ||
| 13284 |
MS- |
209783-80-2 | ≥98% |
|
2009-11-05 | 37.997177716390 | ms-275 | Entinostat; SNDX 275 | inhibitors histone deacetylases HDACs HDAC1 HDAC3 HDAC8 cyclin-dependent kinase inhibitor 1A p21 CIP1 WAF1 cell growth differentiation tumors cancers apoptosis adriamycin PARP Hsp90 ms275 MS 27-275 SNDX-275 SNDX275 MS27275 | 37.997177716390 | ||
| 9001147 |
N- |
192883-12-8 | ≥98% |
|
✓ | 2012-04-19 | 77.182554235372 | n-3-hydroxydecanoyl-l-homoserine-lactone | OH-C10-HSL | bacteria quorum sensing genes regulations infections signal transductions HSLs HL lactones OHC10HL cells growth molecules | 77.182554235372 | |
| 9001150 |
N- |
192883-14-0 | ≥98% |
|
✓ | 2012-04-19 | 77.605403837539 | n-3-hydroxyoctanoyl-l-homoserine-lactone | OH-C8-HSL | bacteria quorum sensing genes regulations infections signals transductions lactones HSL HL cells growth molecules OHC8HL | 77.605403837539 | |
| 10007895 |
N- |
168982-69-2 | ≥98% |
|
2006-07-26 | 40.818766238614 | n-3-oxo-dodecanoyl-l-homoserine-lactone | 3-oxo-C12-HSL | quorum sensing bacteria cystic fibrosis acylhomoserine lactones HSL 3-oxo-C12-HSL 3-(oxo-dodecanoyl)-L-homoserine IL-8 iloprost 3-oxo-C12-Homoserine lactone | 40.818766238614 | ||
| 10011238 |
N- |
- | ≥98% |
|
✓ | 2009-03-30 | 23.139723756906 | n-3-oxo-hexadec-11-z-enoyl-l-homoserine-lactone | 3-oxo-C16:1-Δ11cis-(L)-HSL | 3-O-C16:1-Δ11cis-(L)-HSL AHL quorum sensing signaling autoinducers bacteria Agrobacterium vitis signalling signals HSLs | 23.139723756906 | |
| 10011206 |
N- |
147795-39-9 | ≥98% |
|
2009-06-29 | 6.005074149461 | n-3-oxo-octanoyl-l-homoserine-lactone | N-β-oxo-octanoyl-L-Homoserine lactone; 3-oxo-C8-HSL | AHLs quorum sensing signaling signalling autoinducer gram negative bacterias cells cell-cell communivation A.tumefaciens lactones | 6.005074149461 | ||
| 13213 |
N- |
482598-46-9 | ≥98% |
|
2009-07-08 | 15.720514070071 | n-3-oxo-tetradec-7-z-enoyl-l-homoserine-lactone | 3-oxo-C14:1-Δ7cis-(L)-HSL | AHLs quorum sensing antimicrobial biofilm signaling signalling SAR QSAR immune suppressions bacteria inhibitis inhibitior inhibition | 15.720514070071 | ||
| 13063 |
N- |
177158-19-9 | ≥98% |
|
✓ | 2009-01-29 | 21.390107239333 | n-3-oxo-tetradecanoyl-l-homoserine-lactone | N-3-oxo-myristoyl-L-Homoserine lactone; 3-oxo-C14-HSL | quorum sensing bacteria biofilm gene expressions growth putisolvin lactones HSLs | 21.390107239333 | |
| 10011204 |
N- |
202284-85-3 | ≥98% |
|
✓ | 2008-10-06 | 4.688287292817 | n-butyryl-l-homocysteine-thiolactone | bacterial quorum sensing signaling molecules cell density transcriptional regulators LuxIR protein synthesis N-acylhomoserine lactones AHL cellular metabolism autoinduction | 4.688287292817 | ||
| 10007898 |
N- |
67605-85-0 | ≥95% |
|
2006-04-20 | 24.344548879520 | n-butyryl-l-homoserine-lactone | C4-HSL | bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence slime biofilms transduction activation signalling | 24.344548879520 | ||
| 10007899 |
N- |
- | ≥99% deuterated forms (d1-d5) |
|
2006-05-05 | 15.902984918620 | n-butyryl-l-homoserine-lactone-d5 | C4-HSL-d5 | GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence slime biofilms transduction activation signalling | 15.902984918620 | ||
| 11633 | NCOR2/SMRT (human recombinant) New | - | ≥60% | 2012-04-09 | 85.995493155963 | ncor2-smrt-human-recombinant | TRAC; T3 Receptor-Associating Factor; Nuclear Receptor Corepressor 2; Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor; CTG Repeat Protein 26; SMRT; SMAP270; Thyroid-Retinoic-Acid-Receptor-Associated Corepressor | epigenetics histones deacetylases transcriptional regulations corepressor co-repressor complexes metabolism HDACs HDAC3 class I HDAC yeast Rpd DAD E2F TFIIE TFIIF NF-κB p300 Stat3 p53 retinoblastoma protein Rb protein differentiation cell death angiogenesis inflammation cancers inflammatory diseases | 85.995493155963 | |||
| 10011201 |
N- |
177315-87-6 | ≥96% |
|
2008-09-19 | 13.147814643372 | n-decanoyl-l-homoserine-lactone | C10-HSL | bacterial quorums sensing signaling molecules regulatory cells density infections transcriptional regulators LuxIR N-acylhomerine lactones AHL cellular metabolism virulence | 13.147814643372 | ||
| 10011203 |
N- |
137173-46-7 | ≥98% |
|
✓ | 2009-01-06 | 9.824895288935 | n-dodecanoyl-l-homoserine-lactone | C12-HSL; dDHL | quorum sensing bacteria biofilm gene expressions NF-kb NFkb macrophage keratinocyte C12-Homoserine Lactone | 9.824895288935 | |
| 9000710 |
N- |
- | ≥95% |
|
✓ | 2011-01-17 | 32.394512169628 | n-dodecanoyl-l-homoserine-lactone-3-hydrazone-biotin | N-dodecanoyl-L-HSL-3-hydrazone-biotin | quorum sensing proteolysis affinity probes avidin lactones HSLS biotinamide biotinimide biotins | 32.394512169628 | |
| 9000711 |
N- |
- | ≥98% |
|
2011-01-19 | 36.070322532477 | n-dodecanoyl-l-homoserine-lactone-3-hydrazone-fluorescein | N-dodecanoyl-L-HSL-3-hydrazone-fluorescein | quorum sensing proteolysis fluorescent probes lactones | 36.070322532477 | ||
| 13224 | Neurodazine Exclusive | 937807-66-4 | ≥98% |
|
✓ | 2009-05-18 | 2.821160220994 | neurodazine | neurons neuronal differentiation muscles skeletal myoblasts cells neuron-specific enolase neurofilament 200 synapsin | 2.821160220994 | ||
| 10011198 |
N- |
177158-20-2 | ≥98% |
|
2008-09-25 | 11.434422761052 | n-heptanoyl-l-homoserine-lactone | C7-HSL | bacterial quorums sensing signaling molecules regulatory cells density infections transcriptional regulators LuxIR N-acylhomoserine latones AHL cellular metabolism virulence | 11.434422761052 | ||
| 13064 |
N- |
87206-01-7 | ≥95% |
|
2009-04-06 | 23.401272875085 | n-hexadecanoyl-l-homoserine-lactone | C16-HSL; N-palmitoyl-L-Homoserine | AHL quorum sensing signaling nitrogen fixing membranes vesicles bacteria signalling LUXI SinI | 23.401272875085 | ||
| 10007896 |
N- |
147852-83-3 | ≥98% |
|
2006-04-20 | 23.942372933920 | n-hexanoyl-l-homoserine-lactone | C6-HSL | bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence cystic fibrosis slime biofilms agriculture aquaculture food spoilage septicemia fish activation transduction signalling | 23.942372933920 | ||
| 10007897 |
N- |
- | ≥99% deuterated forms (d1-d3) |
|
2006-05-05 | 16.918012667363 | n-hexanoyl-l-homoserine-lactone-d3 | C6-HSL-d3 | GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence cystic fibrosis slime biofilms agriculture aquaculture food spoilage septicemia fish activation transduction signalling | 16.918012667363 | ||
| 16868 |
N- |
177158-21-3 | ≥98% |
|
2009-03-20 | 22.826963752426 | n-nonanoyl-l-homoserine-lactone | C9-HSL | AHL quorum sensing signaling autoinducer bacteria signalling signals auto-inducer acyl rare odd-numbered carbon C9-(L)-HSL | 22.826963752426 | ||
| 13209 |
N- |
479050-96-9 | ≥98% |
|
✓ | 2009-03-30 | 13.287400925787 | n-octadecanoyl-l-homoserine-lactone | C18-HSL | C18-(L)-HSL AHLs quorum sensing signaling nitrogen fixing membrane vesicles bacteria signalling signals hydrophobic | 13.287400925787 | |
| 10011199 |
N- |
147852-84-4 | ≥98% |
|
2008-10-06 | 10.260212494687 | n-octanoyl-l-homoserine-lactone | OHL; C8-HSL | bacterial quorum sensing signaling molecules cell density transcriptional regulators LuxIR protein synthesis N-acylhomoserine lactones AHL cellular metabolism infection virulence cystic fibrosis | 10.260212494687 | ||
| 13094 |
N- |
182359-66-6 | ≥98% |
|
✓ | 2009-03-02 | 20.503421432482 | n-pentadecanoyl-l-homoserine-lactone | C15-HSL | C15HSL C15-HSL AHL quorum sensing signaling signalling autoinducers bacterias | 20.503421432482 | |
| 13196 | NSC 23766 (hydrochloride) | 1177865-17-6 | ≥98% |
|
2010-07-20 | 18.908674033149 | nsc-23766-hydrochloride | 733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration Aminoquinolines angiogenesis leukemia cancers gene expression Rac1 Inhibitor | 18.908674033149 | |||
| 10758 | NSD2 (human recombinant) New | - | ≥90% |
|
2012-02-01 | 5.306521739130 | nsd2-human-recombinant | Histone-lysine N-methyltransferase NSD2 isoform 1; MMSET; TRX5; Wolf-Hirschorn Syndrome Candidate 1; Nuclear Receptor SET domain-containing protein 2; Multiple myeloma SET domain-containing protein; Protein trithorax-5; WHSC1; KIAA1090 | NSD2 SET-Domains Lysine methyltransferases chromatin WHSC1 MMSET WHSCH1-like multiple myeloma translocations histones H3 H4 H3K36 H4K44 H4K20 53BP1 dimethylation DNA damages NSDs NSD-2 active | 5.306521739130 | ||
| 13093 |
N- |
878627-21-5 | ≥98% |
|
✓ | 2009-03-09 | 23.752078542631 | n-tridecanoyl-l-homoserine-lactone | C13-HSL | C13HSL AHL quorum sensing signaling signalling autoinducers bacterias C13-L-HSL | 23.752078542631 | |
| 16827 |
N- |
216596-71-3 | ≥98% |
|
2009-03-09 | 25.914556837817 | n-undecanoyl-l-homoserine-lactone | C11-HSL | AHLs quorum sensing signaling signalling autoinducer bacteria | 25.914556837817 | ||
| 10011207 |
N- |
143537-62-6 | ≥95% |
|
2009-05-28 | 25.300024865124 | n-ketocaproyl-l-homoserine-lactone | 3-O-C6-(L)-HSL | 3-oxo-C6-HSL AHL quorum sensing signaling autoinducers bacteria cell-cell communication V. fischeri | 25.300024865124 | ||
| 13176 | Oxamflatin | 151720-43-3 | ≥95% |
|
2010-11-16 | 28.367523020257 | oxamflatin | Metacept 3 | HDACs histones deacetylases genes expressions morphology motility apoptosis cells cycles cancers reducing reduction proliferation Acids Hydroxamic Hydroxamic Acids Acid Hydroxamic Hydroxamic Acid | 28.367523020257 | ||
| 13785 | p66α Polyclonal Antibody | - |
|
2010-05-13 | 0E-12 | p66-polyclonal-antibody | Transcriptional Repressor p66α; GATA Zinc Finger Domain-Containing Protein 2A | MBD MeCP CpG methyl-CpG-binding proteins DNA western blots blotting immunoblotting WB antibodies | 0E-12 | |||
| 10784 | PAD1 (human recombinant) | - | ≥95% |
|
2011-05-12 | 47.737265193370 | pad1-human-recombinant | Protein-Arginine Deiminase 1 | PAD1 PADI-1 arginine deiminase post-translational modifications citrullination skin keratinocytes calcium-dependent active | 47.737265193370 | ||
| 10500 | PAD4 (human recombinant) | - | ≥95% |
|
2010-05-27 | 68.342983425414 | pad4-human-recombinant | Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4 | guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase active | 68.342983425414 | ||
| 70080 | Parthenolide New | 20554-84-1 | ≥98% |
|
2012-05-18 | 92.222222222222 | parthenolide | 119325-19-8 120852-67-7 344906-67-8 leishmania apoptosis cancers genes regulations inflammation NF-kB lactones plats feverfew Tanacetum parthenium T. promastigote Leishmania amazonensis L. STAT mediated anti-apoptotic transcriptions inhibits inhibiting inhibition NOD2 | 92.222222222222 | |||
| 10009115 | pCAF Histone Acetyltransferase | - | ≥95% | 2006-10-18 | 20.201293020038 | pcaf-histone-acetyltransferase | HAT; p300/(CREB binding protein) Associated Factor | proteins binding GCN5 nuclear acetyltransferases C-terminal C-terminus acetyl-lysine N-terminal N-terminus histones H3 H4 transcriptional activators MyoD E2F1 p53 acetylates PTEN K125 K128 catalytic cleft in vivo enzymes cancers active | 20.201293020038 | |||
| 11440 | Penicillic Acid New | 90-65-3 | ≥98% |
|
2012-04-18 | 124.444444444445 | penicillic-acid | NSC 402844 | NSC402844 NSC-402844 quorum sensing virulence mycotoxins inhibitors inhibits inhibition bacterial infection Fas apoptosis caspase-8 Burkitt’s lymphoma Penicillium mold corn grains acids Pseudomonas aeruginosa raji genes | 124.444444444445 | ||
| 13212 | Pimelic Diphenylamide 106 Exclusive | 937039-45-7 | ≥98% |
|
✓ | 2009-09-30 | 18.483024134922 | pimelic-diphenylamide-106 | inhibitors inhibits inhibitions class I histone deacetylases HDACs SAHA HDAC1 HDAC2 HDAC3 HDAC8 II HDAC4 HDAC5 HDAC7 benzamides friedrich ataxia huntington disease | 18.483024134922 | ||
| 10009088 | PPARα LBD (human recombinant) | - | ≥90% | 2006-09-13 | 56.225207182320 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor α Ligand Binding Domain | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting | 56.225207182320 | |||
| 61700 | PPARγ FL (human recombinant from E. coli) | - | >90% by SDS-PAGE |
|
2007-01-10 | 27.604745242480 | ppar-fl-human-recombinant-from-e-coli | Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone | 27.604745242480 | ||
| 10009987 | PPARγ FL (human recombinant from Sf21 cells) | - | ≥80% by SDS-PAGE |
|
2007-06-15 | 33.559779005524 | ppar-fl-human-recombinant-from-sf21-cells | Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) | proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology | 33.559779005524 | ||
| 10007941 | PPARγ LBD (human recombinant) | - | ≥90% |
|
2006-03-16 | 20.752995702885 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent | 20.752995702885 | ||
| 10007451 | PPARδ (human recombinant) | - | ≥95% | 2005-07-29 | 13.889472068754 | ppar-human-recombinant | NUC1; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 | 13.889472068754 | |||
| 10009568 | PPARδ Western Ready Control | - | 2007-02-02 | 3.709790055248 | ppar-western-ready-control | Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity | 3.709790055248 | ||||
| 11209 | PRDM9 (human recombinant) Exclusive New | - | ≥65% |
|
✓ | 2012-01-11 | 24.814814814814 | prdm9-human-recombinant | PR Domain-containing Protein 9; MSBP3; ZNF899; PFM6; Meisetz | histones methyltransferases zinc-fingers hotspots recombination genomes genetics meiosis trimethylation H3K4 nucleosomes PR/SET HTMase c-terminal C2-H2 PR domain zinc finger protein 9 | 24.814814814814 | |
| 10350 | PRMT1 (human recombinant) | - | ≥80% |
|
2011-01-25 | 112.131740860628 | prmt1-human-recombinant | Protein Arginine Methyltransferase 1 | PRMT1 brucei Prmt1 TbPRMT1 brucei Silencing Factors Transcriptional Transcriptional Silencing Factors Transcription Factors Repressor Molecules Proteins Repressor Repressor Proteins arginine methyltransferase histones modification glycine arginine rich GAR motifs SAM-dependent GST-tagged active | 112.131740860628 | ||
| 10750 | PRMT4 (human recombinant) New | - | ≥70% |
|
2011-12-21 | 9.138927255985 | prmt4-human-recombinant | Protein Arginine Methyltransferase 4; CARM1; Coactivator-associated Arginine Methyltransferase 1 | PRMT arginine methyltransferases epigenetics PRMT4 CARM1 SAM MMA aDMA Arg-17 Arg-26 proteins enzymes catalytic domains S-adenosyl-L-methionine histones H3 binding binds p160 SRC-1 SRC1 GRIP1 TIF2 pCIP RAC3 ACTR AIB1 TRAM1 nuclear receptors phosphorylation Ser217 hormones regulation lipids metabolism ω-NG,NG-dimethylarginine ω-NG-monomethylarginine active | 9.138927255985 | ||
| 13552 | PRMT4 Polyclonal Antibody | - |
|
2009-07-24 | 0E-12 | prmt4-polyclonal-antibody | CARM1; Protein Arginine Methyltransferase 4 | antibodies WB western immunoblotting blots coactivator associated arginine methyltransferase 1 steroids receptors SRC proteins co-activators blotting | 0E-12 | |||
| 13559 | PRMT5 Polyclonal Antibody | - |
|
2009-07-24 | 2.149650092081 | prmt5-polyclonal-antibody | Protein Arginine Methyltransferase 7; Skb1HS; JBP1 | proteins PRMTs signaling WB western immunoblotting blots ADMA blotting janus kinase-binding kinase binding fission yeast 1 | 2.149650092081 | |||
| 10752 | PRMT6 (human recombinant) New | - | ≥80% |
|
2012-01-24 | 8.669677008074 | prmt6-human-recombinant | Protein Arginine Methyltransferase 6; HRMT1L6; Histone Arginine N-methyltransferase PRMT6; Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 6 | PRMTs arginine methyltransferases epigenetics PRMT6 histones SAM MMA aDMA H3R2 HMA H3K4 MLL HMGA1a active | 8.669677008074 | ||
| 13558 | PRMT6 Polyclonal Antibody | - |
|
2009-07-24 | 2.149650092081 | prmt6-polyclonal-antibody | Protein Arginine Methyltransferase 6 | antibodies WB HeLa proteins western immunoblotting blots blotting | 2.149650092081 | |||
| 13551 | PRMT7 Polyclonal Antibody | - |
|
2009-07-24 | 1.842557221783 | prmt7-polyclonal-antibody | Protein Arginine Methyltransferase 7 | PRMTs antibodies proteins western blotting immunoblotting blots SRC steroid receptor co-activator coactivator GRIP-1 GRIP1 WB | 1.842557221783 | |||
| 10013 |
Prostaglandin A1- |
- | >95% |
|
25.556169429097 | prostaglandin-a1-biotin | PGA1-biotin | antimitotic antiproliferative probes ligands prostaglandins pga1-biotinimides detection affinity complexes DNA nucleic acid protein binding partners mechanism biotins PGA1-biotins PGA1-biotinylated PGA1-biotinamides biotinylated biotinamides | 25.556169429097 | |||
| 10006734 | QNZ | 545380-34-5 | >98% |
|
2005-12-16 | 24.020738950276 | qnz | CAY10470 | inhibits inhibitor inhibition NF kB NF-kB NF-.kappa.B nuclear factors transcription proinflammatory cytokines TNFa TNF.alpha. interleukins IL-1b IL-1.beta. IL-6 IL-8 activation Jurkat cells LPS lipopolysaccharides murine splenocytes in vivo edema carrageenin rat hind paw NF-kappaB nfkb nf-kb NF-.kappa.B | 24.020738950276 | ||
| 10947 | RbBP5 (human recombinant) New | - | ≥90% |
|
2012-01-06 | 14.152052839174 | rbbp5-human-recombinant | SWD1, Set1c WD40 repeat protein, homolog; Retinoblastoma binding Protein 5; RBQ3 | epigenetics methyltransferases histones H3K4 genes regulation MLL proteins complex subunits nuclear WD40 domains tumors supressors RB cells proliferation E1A SET1 lysine MLL1 MLL1-4 dimethylation trimethylation H3 H3K4me2/me3 retinoblastoma-binding protein RBQ-3 RBBP-5 RBBP5 | 14.152052839174 | ||
| 11017 | Retinoic Acid | 302-79-4 | ≥98% |
|
2011-10-25 | 17.543287906690 | retinoic-acid | ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578 | ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans | 17.543287906690 | ||
| 13302 |
RG- |
48208-26-0 | ≥98% |
|
2009-07-16 | 12.834708420414 | rg-108 | N-Phthalyl-L-Tryptophan | DNA methyltransferase methylation demethylation genomic toxicity epigenetics tumors tumor suppressor genes RG108 blocking enzyme active site 5-azacytidine DNMT malignant cells | 12.834708420414 | ||
| 10765 | RIZ1 (human recombinant) New | - | ≥95% |
|
2012-05-02 | 76.169567428508 | riz1-human-recombinant | KMT8; Retinoblastoma Protein-interacting Zinc Finger Protein; PR Domain Zinc Finger Protein 2; PRDM2 | epigenetics cancer Histone H3K9 PR Domain Zinc-Finger histones methyltransferases RIZ-1 RIZ 1 SAM-dependent RIZs tumor suppressor apoptosis methylation | 76.169567428508 | ||
| 11078 |
RORα Polyclonal Antibody (aa 220- |
- |
|
2012-04-19 | 104.444444444444 | ror-polyclonal-antibody-aa-220-270 | NR1F1; RAR-Related Orphan Receptor A; RZR-α | receptors retinoic acids NR1 subfamily nuclear hormones DNA binding domains genes expression cells functions NM23-2 NM23-1 CDK7 NCOA3 NCOA6 coactivators mesenchymal stem cells bones marrow acute promyelocytic leukemia APL western blots blotting Nuclear Receptor RZR alpha Nuclear receptor RZR-alpha Nuclear Receptor RZR-alpha Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor alpha Retinoid-related orphan receptor-alpha Retinoid-Related Orphan Receptor-alpha RZR alpha RZR-alpha, Nuclear Receptor nuclear receptor ROR-alpha retinoic acid receptor-related orphan receptor alpha RORalpha | 104.444444444444 | |||
| 11077 |
RORα Polyclonal Antibody (aa 80- |
- |
|
2012-04-05 | 104.444444444444 | ror-polyclonal-antibody-aa-80-120 | receptors retinoic acids NR1 subfamily nuclear hormones DNA binding domains genes expression cells functions NM23-2 NM23-1 CDK7 NCOA3 NCOA6 coactivators mesenchymal stem cells bones marrow acute promyelocytic leukemia APL western blots blotting Nuclear Receptor RZR alpha Nuclear receptor RZR-alpha Nuclear Receptor RZR-alpha Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor alpha Retinoid-related orphan receptor-alpha Retinoid-Related Orphan Receptor-alpha RZR alpha RZR-alpha, Nuclear Receptor nuclear receptor ROR-alpha retinoic acid receptor-related orphan receptor alpha RORalpha | 104.444444444444 | ||||
| 13178 | Salermide | 1105698-15-4 | ≥98% |
|
2009-04-27 | 19.070710339384 | salermide | Sirtuin SIRT1 SIRT2 inhibitors cancers apoptosis leukemias histone deacetylases HDACS inhibition inhibited | 19.070710339384 | |||
| 10572 | Scriptaid | 287383-59-9 | ≥98% |
|
2010-09-27 | 43.534185082873 | scriptaid | GCK 1026 | histones deacetylases HDACs inhibitors inhibition inhibits cancers cloning cells arrest somatic nuclear transfers Scriptides trichostatin A mouse inbred strains somaic GCK-1026 GDK1026 hydroxylamines | 43.534185082873 | ||
| 10320 | SET7/9 (human recombinant) | - | ≥95% | 2009-08-11 | 24.024535383748 | set7-9-human-recombinant | KMT7; SETD7/9; SET Domain-containing Protein 7/9 | SET-7/9 SET 7/9 7 9 recombinant His-tagged proteins SETs methylation methyltransferase active | 24.024535383748 | |||
| 13731 | SET7/9 Polyclonal Antibody | - |
|
2009-11-25 | 35.149309392265 | set7-9-polyclonal-antibody | antibodies SET 7/9 SET-7/9 7 9 histones H3 lysines 4 western blotting WB blots immunoblotting | 35.149309392265 | ||||
| 10319 | SET8 (human recombinant) | - | ≥95% |
|
2010-01-07 | 16.373424505296 | set8-human-recombinant | SETD8; SET domain-containing (lysine methyltransferase) 8; KMT5a; PR-Set7 | SET-8 SET 8 recombinant His-tagged proteins SETs methylation methyltransferase MTs domain containing active | 16.373424505296 | ||
| 10767 | SETD2 (human recombinant) New | - | ≥95% |
|
2012-01-19 | 10.685672191528 | setd2-human-recombinant | p231HBP; Huntington Interacting Protein B; KMT3A; HYPB | epigenetics histones methyltransferases SET-domains containing SETD-2 SETD 2 huntingtin interacting proteins b HYBP trimethylation H3K36me3 mouse fibroblasts cells mono-methylation di-methylation WW hyperphosphorylation RNA polymerase II regulation diseases | 10.685672191528 | ||
| 10011190 | SIRT1 (human recombinant) | - | ≥60% | 2008-09-24 | 19.030764272559 | sirt1-human-recombinant | Silent Information Regulator 2; Sirtuin 1; SIR2-like Protein 1; SIR2L1; NAD-dependent Deacetylase 1 | SIRT 1 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 1 SIR2alpha sirtuin type 1 active | 19.030764272559 | |||
| 10011191 | SIRT2 (human recombinant) | - | ≥90% | 2009-07-31 | 16.713987108655 | sirt2-human-recombinant | Silent Information Regulator 2; Sirtuin 2; SIR2-like Protein 2; NAD-dependent Deacetylase 2; SIR2L2 | SIRT 2 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers His-tagged His tag sirtuin silent mating type information regulation 2 homolog 2 sirtuin type 2 active | 16.713987108655 | |||
| 10011194 | SIRT3 (human recombinant) | - | ≥90% |
|
2008-12-15 | 25.532397790055 | sirt3-human-recombinant | SIR2L3; Mitochondrial Nicotinamide Adenine Dinuclear-dependent Deacetylase; SIR2-like Protein 3; NAD-dependent Deacetylase 3; Silent Information Regulator 3; Sirtuin 3 | SIRT 3 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 3 sirtuin type 3 sir2-like 3 active | 25.532397790055 | ||
| 10317 | SIRT4 (human recombinant) | - | ≥95% |
|
2010-01-06 | 9.452173112338 | sirt4-human-recombinant | Sirtuin 4; Silent Information Regulator 4; SIR2L4; SIR2-like Protein 4; NAD-dependent ADP-ribosyltransferase Sirtuin 4 | SIRTs Sirtuins HDACs proteins His-tagged hexahistidines HDACS histone decatylases GDH glutamate dehydrogenase sirtuin silent mating type information regulation 2 homolog 4 sirtuin type 4 | 9.452173112338 | ||
| 10318 | SIRT5 (human recombinant) | - | ≥90% | 2009-07-31 | 18.494220994474 | sirt5-human-recombinant | Silent Information Regulator 5; Sirtuin 5; SIR2L5; SIR2-like Protein 5; NAD-dependent Deacetylase 5 | SIRTs proteins HDACs CSP1 GST-tagged silent mating type information regulation 2 homolog 5 sirtuin type 5 | 18.494220994474 | |||
| 10315 | SIRT6 (human recombinant) | - | ≥95% | 2009-07-31 | 16.179944751381 | sirt6-human-recombinant | Sirtuin 6; NAD-dependent Deacetylase 6; Silent Information Regulator 6; SIR2L6; SIR2-like Protein 6 | SIRTs Sirtuins HDACs proteins His-tagged hexahistidine silent mating type information regulation 2 homolog 6 sirtuin type 6 active | 16.179944751381 | |||
| 10316 | SIRT7 (human recombinant) | - | ≥85% |
|
2009-12-22 | 13.922508287293 | sirt7-human-recombinant | SIR2L7; Sirtuin 7; Silent Information Regulator 7; SIR2-like protein 7; NAD-dependent deacetylase 7 | SIRTs Sirtuins HDACs proteins His-tagged hexahistidine histone deacetylases silent mating types information regulators 2 homologs | 13.922508287293 | ||
| 10822 | SMAD1/5/8/9 Polyclonal Antibody | - |
|
2011-04-14 | 0.753496448303 | smad1-5-8-9-polyclonal-antibody | WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum 1,5,8,9 | 0.753496448303 | ||||
| 10821 | SMAD1/5/8/9 Polyclonal Antiserum | - |
|
2011-03-31 | 0.753496448303 | smad1-5-8-9-polyclonal-antiserum | WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum | 0.753496448303 | ||||
| 10823 | SMAD2 Polyclonal Antibody | - |
|
2011-05-05 | 0.753496448303 | smad2-polyclonal-antibody | WBs western blots immunoblotting SMADs SMAD-2 SMAD 2 antibodies serum IHC immunohistochemistry TGF-β TGFβ cancers | 0.753496448303 | ||||
| 10832 | SMAD3 Polyclonal Antibody | - |
|
2011-05-03 | 0.659309392265 | smad3-polyclonal-antibody | WBs western blots immunoblotting SMADs SMAD-3 SMAD 3 antibodies serum IHC immunohistochemistry TGF-β TGFβ Tcells signaling TGF-β MH1 domains DNA proteins SARA ECM apoptosis proliferation differentiation | 0.659309392265 | ||||
| 10838 | SMAD4 Polyclonal Antibody | - |
|
2011-05-05 | 2.900856353591 | smad4-polyclonal-antibody | WBs western blots immunoblotting SMADs SMAD-4 SMAD 4 antibodies serum IHC immunohistochemistry TGF-β TGFβ cancers | 2.900856353591 | ||||
| 10839 | SMAD6 Polyclonal Antibody | - |
|
2011-05-02 | 1.814269928965 | smad6-polyclonal-antibody | WBs western blots immunoblotting SMADs MAD SMAD-6 SMAD 6 antibodies serum IHC immunohistochemistry TGF-β TGFβ Tcells intracellular proteins signaling serine threonine apoptosis bones cancers genes signal transduction | 1.814269928965 | ||||
| 10845 | SMAD7 Polyclonal Antibody | - |
|
2011-05-05 | 0.753496448303 | smad7-polyclonal-antibody | WBs western blots immunoblotting SMADs SMAD-7 SMAD 7 antibodies serum TGF-β TGFβ Tcells | 0.753496448303 | ||||
| 10840 |
SMAD7 Polyclonal Antibody (azide- |
- |
|
2011-05-05 | 1.950055248618 | smad7-polyclonal-antibody-azide-free | WBs western blots immunoblotting SMADs SMAD-7 SMAD 7 antibodies serum TGF-β TGFβ Tcells | 1.950055248618 | ||||
| 13121 | Sodium Butyrate | 156-54-7 | ≥95% |
|
2009-07-31 | 57.741817065684 | sodium-butyrate | Butyric Acid (sodium salt) | fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg | 57.741817065684 | ||
| 13168 | Splitomicin | 5690-03-9 | ≥98% |
|
2010-07-15 | 13.082355958958 | splitomicin | 1-Naphthalenepropanoic Acid | sirtuins Sir2p Sir-2p Sir 2p SIR2 NAD NAD+-dependent NAD-dependent dependent histone deacetylase activity activities genes regulations lifespan life-span life span yeast expression DNA replication inhibitor inhibits inhibition Hst1 Hst-1 Hst 1 HDACs chromatin research epigenetics regulation modification Sirs small molecules Pyrones | 13.082355958958 | ||
| 81590 | Staurosporine | 62996-74-1 | >98% |
|
21.359733917571 | staurosporine | Stsp | inhibitor inhibits protein kinase pkc-alpha pkc-.alpha. eNOS endothelial nitric oxide synthases | 21.359733917571 | |||
| 10574 | Suberohydroxamic Acid | 38937-66-5 | ≥98% |
|
2010-09-28 | 21.781184392264 | suberohydroxamic-acid | SBHA; Suberic bis-Hydroxamic Acid | histones deacetylases HDACs inhibitors genes expression regulation epigenetics nucleosomes HDAC1 HDAC3 differentiation cells cycle arrest apoptosis cancers suberodihydroxamic acid suberoyl bishydroxamic acid inhibited inhibition Warner-Lambert Brand of Mefenamic Acid Warner Lambert Brand of Mefenamic Acid Pharmascience Brand of Mefenamic Acid First Horizon Brand of Mefenamic Acid Parke Davis Brand of Mefenamic Acid Farmasierra Brand of Mefenamic Acid Ashbourne Brand of Mefenamic Acid Pinewood Brand of Mefenamic Acid Nu-Pharm Brand of Mefenamic Acid Nu Pharm Brand of Mefenamic Acid Chemidex Brand of Mefenamic Acid Gödecke Brand of Mefenamic Acid Clonmel Brand of Mefenamic Acid Antigen Brand of Mefenamic Acid Pfizer Brand of Mefenamic Acid Apotex Brand of Mefenamic Acid Rowa Brand of Mefenamic Acid Elan Brand of Mefenamic Acid APS Brand of Mefenamic Acid PMS-Mefenamic Acid PMS Mefenamic Acid Acid Mefenaminic Mefenaminic Acid Acid Mefenamic Mefenamic Acid Forte Ponstan Ponstan Forte Apo-Mefenamic Apo Mefenamic Nu-Mefenamic Nu Mefenamic ApoMefenamic NuMefenamic Pinalgesic Contraflam Ponalgic Parkemed Ponstel Ponstan Ponalar Mefacit Pontal Ponsyl Ponmel Dysman Coslan Mefic Mefac | 21.781184392264 | ||
| 10763 |
SUV4- |
- | ≥60% |
|
2011-07-13 | 32.081229281768 | suv4-20h1-human-recombinant | KMT5B; Suppressor of Variegation 4-20 Homolog 1; Lysine N-methyltransferase 5B | methyltranferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysines methylation epigenetics genes regulations KMT5B trimethylation H4K20 GRIP1 KMT5C KMT-5B KMT-5C KMTs active | 32.081229281768 | ||
| 10764 |
SUV4- |
- | ≥95% |
|
2011-06-06 | 32.572251381215 | suv4-20h2-human-recombinant | Suppressor of Variegation 4-20 Homolog 2; KMT5C | methyltransferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysine methylation epigenetics genes regulation SETD8 Pr-SET7 SUV420H2 SUV-420H2 SUV 420H2 SUV420H1 SUV-420H1 SUV 420H1 active | 32.572251381215 | ||
| 11629 | Tamoxifen (citrate) New | 54965-24-1 | ≥98% |
|
2012-04-04 | 71.420949142938 | tamoxifen-citrate | ICI 46474; Nolvadex; Istubal; Noltam; Kessar; TMX; Valodex; Zemide | 7244-97-5 I.C.I.46474 citrate tamofen tamoplex tamox-puren tomaxasta Z-tamoxifen citrate nourytam ICI-46474 ICI46474 estrogen receptors cancers breasts agonists antagonists cholesterol modulators ER adjuvants bones uterus tissues cytochromes P450 CYP450 endoxifen cells apotosis autophagy differentiation | 71.420949142938 | ||
| 13788 | TBLR1 Polyclonal Antibody | - |
|
2010-05-24 | 11.767955801105 | tblr1-polyclonal-antibody | Transducin β-Like 1X-Related Protein 1; F-Box-Like/WD Repeat-Containing Protein | antibodies WB western blots blotting immunoblotting TBLR-1 TBLR 1 N-CoR NCoR N CoR SMRT nuclears receptors corepressors retinoid thyroid hormones HDACs histones deacetylases HDAC3 HDAC-3 3 TBL1X1R | 11.767955801105 | |||
| 10398 | TG003 | 300801-52-9 | ≥95% |
|
2011-08-17 | 3.845303867404 | tg003 | inhibitors CDC kinasesTG 003 TG-003 TG3 TG-3 TG 3 Cdc2-like kinases Clks serine/arginine-rich proteins splicing RNA Clk1/Sty Clk4 serine rich pre-mRNA Xenopus arginine SR mRNA Sty Clk1 CLk2 Clk3 Clk4 benzothiazole inhibition inhibits inhibitor SF2 SF2/ASF ASF | 3.845303867404 | |||
| 10783 | TIP60 (human recombinant) New | - | ≥80% |
|
2012-02-27 | 13.967022262195 | tip60-human-recombinant | Hs.6364; HIV-1 Tat Interacting Protein 60 kDa; Esa1; HTATIP; cPLA(2) Interacting Protein; KAT5; PLIP | histones acetyl transferases HATs KAT5 KATs lysine acetyltransferases Tip-60 epigenetics histones modifications MYST Ataxia Telangiectasia Mutants p400 complex γH2AX iTIP60 Tip-60 | 13.967022262195 | ||
| 13789 | TIP60 Polyclonal Antibody | - |
|
2010-05-24 | 7.423494475138 | tip60-polyclonal-antibody | KAT5; Lysine Acetyltransferase 5 | antibodies TIP-60 TIP 60 TIPs HDACs western blots blotting immunblotting immunohistochemsitry IHC histones DAN proteins transcription factors | 7.423494475138 | |||
| 13631 | UNC0224 Exclusive | 1197196-48-7 | ≥98% |
|
✓ | 2010-08-10 | 21.928835529111 | unc0224 | inhibitors inhibits inhibition histones methyltransferases genes regulation regulator chromatin remodeling UNC 0224 UNC-0224 G9a SET8 SET7/9 lysine HMTase | 21.928835529111 | ||
| 10582 | UNC0321 (trifluoroacetate salt) Exclusive | - | ≥95% |
|
✓ | 2011-03-15 | 13.187769964842 | unc0321-trifluoroacetate-salt | methyltransferases inhibitors histones genes regulation chromatin remodeling G9a HMTase inhibited inhibition potent selective MT SET7/9 SET8 PRMT3 JMJD2E | 13.187769964842 | ||
| 10734 | UNC0638 | 1255580-76-7 | ≥98% |
|
2011-05-03 | 22.094889502762 | unc0638 | methyltransferases inhibitors histones genes regulation chromatin remodeling inhibited inhibition G9a MT GLP PRMT 3 SUV39H2 SET7/9 SET8 inhibits H3K9 dimethylation MDA-MB231 | 22.094889502762 | |||
| 10774 | UTX (human recombinant) | - | ≥85% |
|
2011-05-24 | 19.139403519541 | utx-human-recombinant | Ubiquitously Transcribed Tetratricopeptide Repeat X; KDM6A | epigenetics histones lysines demthylases chromatins regulators dioxygenases JmjC proteins enzymes recombinants UTY genes chromosomes active | 19.139403519541 | ||
| 10944 | WDR5 (human recombinant) | - | ≥95% |
|
2011-08-05 | 14.152052839174 | wdr5-human-recombinant | BMP2-induced 3-kb Gene Protein; SWD3, Set1c WD40 repeat protein, homolog; WD-Repeat Protein 5; BIG3 | epigenetics binding proteins methyltransferase MLL complex subunits | 14.152052839174 | ||
| 11549 | WDR9 bromodomain 2 (human recombinant) New | - | ≥85% |
|
2012-03-01 | 15.723401238237 | wdr9-bromodomain-2-human-recombinant | WD repeat-containing protein 9; BRD and WD repeat-containing protein 1 | genes expressions histones chromatin acetylation bromodomains epigenetics BET domain WD repeats Brg1 SMARCA4 | 15.723401238237 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search